WuXi XDC

We’d like to extend our sincere thanks to each of you who dropped our booth, shared ideas and made it fruitful experience! #BioJapan2024 #BiotechInnovation #PharmaIndustry #CRDMO #PacificoYokohama #BiotechNetworking #BiotechCommunity

Visit us at Booth #1128 during the Festival of Biologics from October 15-17 in Basel, Switzerland! Don't miss the opportunity to hear from Dr. Jimmy L., CEO of WuXi XDC, as he’ll present valuable insights on "Accelerating ADC Development From DNA to BLA Through Fully Integrated CMC and Manufacturing Platforms". We’ll also have an engaging panel discussion on "Accelerating ADC and Bioconjugates Development" to explore the diversified development prospects from ADC to XDC and strategies to accelerate the development of bioconjugates. Looking to discuss outsourcing or partnering opportunities? Contact us to schedule a convenient time to meet during the event. https://lnkd.in/guvvwrnY

Traditional bioconjugate development required an extensive network of partners often spread across different site. However, our “All-in-One” facilities operational in the Wuxi city site has encompassed mAb intermediates, payload-linker, as well as ADC DS and DP, the entire ADC supply chain within one single site. Our "All-in-One" manufacturing strategy simplifies the entire process, offering significant advantages for your bioconjugate projects: 🛡 Lowered Risks 💰 Reduced Costs ⏱️ Accelerated Timelines Connect to our experts today: https://lnkd.in/eCgHTVqf #bioconjugation #biomanufacturing #biopharma #biologics #biotherapeutics #ADC #antibodydrugconjugate

Attending the BioJapan 2024 during this week at PACIFICO Yokohama, Japan? Don’t miss the insightful presentation by Dr. Jimmy L., CEO of WuXi XDC, on "Accelerate ADC CMC Development and commercialization with WuXi XDC's Fully Integrated CRDMO Services". In addition, Dr. Jun Hu, Head of Client Enabling Center of Excellence of WuXi XDC will join forces with Dr. Feng Xu, Director of CMC Management at WuXi Biologics, to present a talk on "IND-enabling Platform for R&D, Manufacturing of mAbs and ADCs". Our experts will also be available at booth #D35 to discuss your bioconjugates’ outsourcing needs, schedule a meeting with our experts: https://lnkd.in/guvvwrnY

WuXi XDC offers comprehensive CRDMO services that span from intermediates to bioconjugates, covering antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. Our integrated, comprehensive platform can accelerate your path to the clinic and beyond by providing enhanced efficiency, flexibility, lowered risks, fewer costs, and industry-leading timelines. Find more details about our services, explore here: https://lnkd.in/dqX-2YXr  

Will you be attending the 15th annual World ADC Event Series in SAN DIEGO during Nov. 4-7? We’ll be at Booth #310 to showcase our integrated CRDMO services for Bioconjugate, Dr. Marie Z. , CTO of WuXi XDC, will give a speech on “Accelerating Novel ADC Development through WuXi XDC’s Innovation Technology and Integrated Development/Manufacturing Platform” on Tuesday, November 5th, 5:30 pm PST. Look forward to seeing you there! Schedule a meeting with us: https://lnkd.in/guvvwrnY

Meet us at Booth #D35 during BioJapan 2024 at PACIFICO Yokohama, Japan, for an engaging discussion and conversation with our team. Excitingly, our expert Dr. Jun Hu, Head of Client Enabling Center of Excellence of WuXi XDC will join forces with Feng Xu, CMC Associate Director of WuXi Biologics, to present a talk on "IND-enabling Platform for R&D, Manufacturing of Abs and ADC" at 4:10PM JST, October 9th. They will share their valuable insights and experiences in enabling Abs and ADCs through cutting-edge platforms. We look forward to connecting with you at Bio Japan 2024! Register now to secure your spot and schedule a meeting with us: https://lnkd.in/guvvwrnY

Join us for a compelling panel discussion themed “Accelerate ADC and Bioconjugates Development” during the Festival of Biologics (October 15-17) in Basel, Switzerland! We are very honored to have Ulf Grawunder, Co-founder and CEO of T-CURX, as the panel moderator, and Jack Elands, CEO of Adcytherix SAS, Christian Klein, Dept. Head of Roche Pharmaceutical Research and Early Development, and Dragan Grabulovski, CEO of Araris Biotech, along with Dr. Jimmy L. , CEO of WuXi XDC, as panelists. Join us to explore the diversified development prospects from ADC to XDC and strategies to accelerate the development of bioconjugates. Look forward to seeing you there! Schedule a meeting with us: https://lnkd.in/guvvwrnY

DAR analysis is a critical aspect of the development of ADC and Bioconjugates, and it significantly influences the efficacy and safety of the Bioconjugates. An optimal DAR can maximize the drug's therapeutic benefits while minimizing side effects. At WuXi XDC, various DAR analytical methods can be provided according to the molecules, including MS, UV, HILIC, RP, HIC, ensuring precise and comprehensive DAR determination for your Bioconjugates’ development needs. Explore our analytical capabilities here: https://lnkd.in/gHFF4Kub

📣 Last minute to register the insightful webinar "Accelerating ADC Drug Development with Technology Innovation and Integrated Platform". During this session, Dr. Bingquan (Stuart) Wang, a Senior Director of US-EU CMC Management at WuXi XDC with extensive CMC experiences in ADC and bioconjugation field, will delve into how to overcome hurdles with advanced CMC expertise and innovative technologies.   Key Takeaways: 💡 Facing main challenges across the ADC field. 💡 Learning strategies to overcome these challenges. 💡 Discovering how to accelerate CMC development for IND. 💡 Understanding strategies to accelerate BLA development. 💡 Analyzing case studies.   Find more info and to register for this webinar: https://lnkd.in/gRi7qUzV